Key elements include developing and commercializing an innovative sample-to-insight workflow incorporating the GeneReader™ benchtop NGS sequencer with the QIAcube and QIAcube NGS instruments for full automation of pre-analytical steps, and also integrating the market-leading biological data analysis, interpretation and reporting capabilities provided by CLC bio and Ingenuity. QIAGEN is delivering on a strategic initiative to create an industry-leading portfolio of products and services to drive the adoption of next-generation sequencing (NGS) in clinical research and diagnostics. Ingenuity Pathway Analysis Server Plugin Long Read Support Server Plugin (Beta). Contact your systems office or TS Bioinformatics. QIAGEN CLC Genomics Workbench 22.0.2 QIAGEN CLC Main Workbench 22.0.2. NGS initiative from biological sample to valuable molecular insights QIAGENs CLC Biomedical Genomics Workbench enables researchers to analyze NGS data without the use of.
The “cross-platform” systems offered by CLC bio support all major NGS platforms. CLC bio’s leading products are CLC Genomics Workbench, a comprehensive and user-friendly analysis package for analyzing, comparing and visualizing NGS data and CLC Genomics Server, a flexible enterprise-level infrastructure and analysis backbone for NGS data analysis. QIAGEN CLC User Group Meeting (May 26 and 27, 2020) Watch the on-demand presentations from this online event, including talks on QIAGEN CLC core and advanced capabilities, use cases from KOLs and a discussion on SARS-CoV-2 analysis using CLC Genomics Workbench. The addition of this portfolio follows QIAGEN’s recent acquisition of Ingenuity Systems, Inc., the market leader in solutions for handling biological data through the interpretation and reporting stages. of QIAGEN CLC Genomics Workbench by adding features to support microbial and metage- nomics (microbial typing, antimicrobial resistance and metagenomics. QIAGEN CLC Genomics resources for microbial and viral genomics Webinars.
CLC bio’s products are used as an integrating workbench to handle biological data generated by a sequencer through a series of analysis stages. Yet a lack of well integrated analytics for microbial genomics leaves researchers and organisations with the burden of integrating and maintaining all the required bioinformatics, statistics and visualisation tools required to power their research. Ever-growing sample volumes demand efficient bioinformatics. It serves leading research institutions and top pharmaceutical companies worldwide. From data to discovery with QIAGEN CLC Genomics Workbench Premium. It strengthens QIAGEN’s rapidly emerging portfolio of “universal” products that can be used with any NGS sequencer as well as providing a key element to the portfolio of automated solutions for the GeneReader™ benchtop NGS sequencer workflow, which is currently in late-stage development.ĬLC bio, a privately-held company based in Aarhus, Denmark, was founded in 2005 and has created the leading commercial data analysis solutions and workbenches for NGS.